PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723113. A total of 42 filers reported holding PEAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $374 | -87.2% | 19,557 | 0.0% | 0.00% | – |
| Q4 2022 | $2,912 | -2.9% | 19,557 | +1.7% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 19,230 | +0.5% | 0.00% | – |
| Q2 2022 | $2,000 | -87.5% | 19,129 | -6.0% | 0.00% | – |
| Q1 2022 | $16,000 | +33.3% | 20,342 | +5.6% | 0.00% | – |
| Q4 2021 | $12,000 | – | 19,263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LMR Partners LLP | 1,940,169 | $2,988,000 | 0.05% |
| Telemetry Investments, L.L.C. | 85,742 | $10,000 | 0.01% |
| DIFESA CAPITAL MANAGEMENT, LP | 151,435 | $19,000 | 0.01% |
| Arena Investors LP | 126,122 | $20,000 | 0.01% |
| ANGELO GORDON & CO., L.P. | 33,332 | $51,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,997,057 | $252,000 | 0.01% |
| Silver Rock Financial LP | 188,505 | $23,000 | 0.01% |
| MYDA Advisors LLC | 57,162 | $9,000 | 0.00% |
| ADVISORY RESEARCH INC | 213,551 | $28,000 | 0.00% |
| BCK CAPITAL MANAGEMENT LP | 12,768 | $2,000 | 0.00% |